Literature DB >> 31470995

Lack of clinical activity with crizotinib in a patient with FUS rearranged rhabdomyosarcoma with ALK protein overexpression.

Jeremy Lewin1, Jayesh Desai2, Kortnye Smith3, Stephen Luen3, Daniel Wong4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31470995     DOI： 10.1016/j.pathol.2019.07.004

Source DB:  PubMed          Journal:  Pathology        ISSN： 0031-3025            Impact factor:   5.306


× No keyword cloud information.
  2 in total

1.  EWSR1-TFCP2 in an adolescent represents an extremely rare and aggressive form of intraosseous spindle cell rhabdomyosarcomas.

Authors:  Agnesa Panferova; Kseniya Yu Sinichenkova; Meriam Abu Jabal; Natalia Usman; Anastasya Sharlai; Vitalii Roshchin; Dmitry Konovalov; Alexander Druy
Journal:  Cold Spring Harb Mol Case Stud       Date:  2022-06-29

2.  Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases.

Authors:  Bin Xu; Albert J H Suurmeijer; Narasimhan P Agaram; Lei Zhang; Cristina R Antonescu
Journal:  Histopathology       Date:  2021-05-19       Impact factor: 7.778
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.